DOH 19TH NATIONAL HEALTH RESEARCH FORUM FOR ACTION KICK OFF EVENT

RE-APPOINTMENT OF HEALTH TECHNOLOGY ASSESSMENT COUNCIL CORE COMMITTEE AND SUBCOMMITTEE MEMBERS

UK NICE INTERNATIONAL KNOWLEDGE EXCHANGE ON GUIDELINE DEVELOPMENT

HTAC'S PRELIMINARY LIST OF PRIORITY TOPICS FOR HTA 2022

Extension of Deadline for Topic Nomination Submissions

HTAC Calls for Topic Nomination

HTA Philippines Facebook Page

HTA and the COVID-19 pandemic

DOH Releases New Implementing Guidelines on HTA

DOH holds first HTA public consultation

DOH holds HTA Workshop and Policy Symposium

Towards UHC: DOH and PhilHealth gear up for HTA

DOH holds high-level forum to accelerate HTA

DOH convenes local experts to create HTAC

HTAC Recommend for Potassium Citrate for inclusion in the PNF

HTAC Recommend for Tocilizumab for inclusion in the PNF

HTAC RECOMMENDATION: COVID-19 VACCINE COVOVAX

HTAC RECOMMENDATION: COVID-19 VACCINE SPUTNIK V

HTAC RECOMMENDATION: COVID-19 VACCINE SINOPHARM

HTAC RECOMMENDATION: COVID-19 VACCINE COVAXIN

HTAC Recommends COVID-19 Vaccine Booster and Additional dose: Guidance and Conditions on Implementation

HTAC GUIDANCE: COVID-19 VACCINATION AMONG THE ADOLESCENT POPULATION

GABAY NG HTAC PARA SA PAGBABAKUNA NG KABATAANG FILIPINO

COVID-19 VACCINES EVIDENCE SUMMARY HTAC PRESS RELEASE

COVID-19 VACINE MODERNA GUIDANCE FOR THE GENERAL PUBLIC

COVID-19 VACINE MODERNA GUIDANCE FOR HEALTH CARE PROVIDERS

COVID-19 VACINE JANSSEN GUIDANCE FOR THE GENERAL PUBLIC

COVID-19 VACINE JANSSEN GUIDANCE FOR HEALTH CARE PROVIDERS

COVID-19 VACINE GAMALEYA GUIDANCE FOR THE GENERAL PUBLIC

COVID-19 VACINE GAMALEYA GUIDANCE FOR HEALTH CARE PROVIDERS

COVID-19 VACCINE SINOVAC GUIDANCE FOR THE GENERAL PUBLIC

COVID-19 VACCINE SINOVAC GUIDANCE FOR HEALTH CARE PROVIDERS

COVID-19 VACCINE ASTRAZENECA GUIDANCE FOR PATIENTS

PFIZER-BIONTECH COVID-19 VACCINE GUIDANCE FOR PATIENTS

COVID-19 VACCINE ASTRAZENECA GUIDANCE FOR HEALTH CARE PROVIDERS

HTAC recommends COVID-19 Vaccine AstraZeneca under emergency use for reducing COVID-19 risk in persons aged 18 and older

PFIZER-BIONTECH COVID-19 VACCINE for health care providers

HTAC recommends Pfizer-BioNTech COVID-19 Vaccine under emergency use for reducing COVID-19 risk in persons aged 16 and older

HTA Philippines publishes HTAC Evaluation Framework for COVID-19 Vaccines

HTAC recommends pooled RT-PCR testing to monitor COVID transmission in populations with low case numbers

HTAC recommends Rapid Antigen Test kits for symptomatic COVID-19, contact tracing, managing outbreaks and supplementing lack of RT-PCR confirmatory testing

HTAC releases guidance for ECMO, notes insufficient evidence to recommend use